Search for: "LaBelle v. LaBelle"
Results 7681 - 7700
of 12,213
Sorted by Relevance
|
Sort by Date
4 Jan 2018, 3:00 am
The District Court found Plaintiff’s argument depended on a broad reading of the Third Circuit’s decision in Kaufman v. [read post]
23 May 2019, 9:30 pm
Food and Drug Administration (FDA) would have declined to add a warning to the allegedly harmful drug’s label, failure-to-warn lawsuits under state law are barred due to a conflict with federal labeling regulations. [read post]
25 Jul 2024, 3:10 pm
Today, in Berkheimer v. [read post]
23 Jul 2010, 5:32 am
One of the folders labeled `Mar’ contained a six-page listing of images. [read post]
19 Mar 2024, 4:41 am
In Texas v. [read post]
24 Feb 2015, 10:00 am
Nicosia v. [read post]
4 Dec 2022, 9:01 pm
Bruen and West Virginia v. [read post]
15 Jun 2011, 12:50 am
Second, and giving all appropriate weight to what was said in R (C (A Minor)) v Secretary of State for Justice [2008] EWCA Civ 882, [2009] QB 657, and E v Chief Constable of the Royal Ulster Constabulary and another (Northern Ireland Human Rights Commission and others intervening) [2008] UKHL 66, [2009] 1 AC 536, the circumstan [read post]
17 Aug 2020, 6:54 am
Sen v. [read post]
3 Jan 2012, 1:05 pm
* The economics of the record label-online music site deals look very, very bad for the music sites [read post]
27 Feb 2023, 3:00 am
” In Snyder v. [read post]
1 Aug 2024, 9:05 pm
Supreme Court’s decision in Dobbs, which overturned Roe v. [read post]
4 Dec 2021, 6:38 am
The marketing of cannabis in Canada, including promotions, displays, labelling and packaging of cannabis, cannabis accessories and related services, is heavily restricted. [read post]
15 Dec 2013, 4:00 am
C.A., December 23, 2011) (34647)(34649) Nov. 22, 2013 ‘Private label’ generic drug pricing regulations are intra vires. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
24 Jan 2013, 10:20 am
Blehm v. [read post]
30 Dec 2011, 3:45 am
See Green v. [read post]
18 Nov 2016, 6:18 am
Here: The Consequences Of Divide-And-Conquer: Carcieri Redux In Carcieri v. [read post]
22 Jul 2008, 3:35 pm
This is a follow up of a post from earlier this week: Open Tech: Ain’t Skeert of Apple v. [read post]
20 Jun 2007, 8:50 am
See, Biomedino, LLC v. [read post]
